Acrivon Therapeutics
ACRV
ACRV
62 hedge funds and large institutions have $140M invested in Acrivon Therapeutics in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 15 reducing their positions, and 5 closing their positions.
Holders
62
Holders Change
+8
Holders Change %
+14.81%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
18
Reduced
15
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
ACA
1
Acorn Capital Advisors
New York
|
$2.44M |
2 |
2
BlackRock
New York
|
$5.69M |
3 |
3
Goldman Sachs
New York
|
$1.43M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$4.04M |
5 |
UOC
5
UBS O'Connor
Chicago,
Illinois
|
$619K |